SK278127B6 - 2-hydroxy-1,2,3-propanetricarboxylate (1:1) 3-£(5-methyl-2- -furanyl) methyl|-n-(4-piperidinyl)-3h-imidazo£4,5-b| pyridine- -2-amine, method of its preparation and pharmaceutical agent on its base - Google Patents

2-hydroxy-1,2,3-propanetricarboxylate (1:1) 3-£(5-methyl-2- -furanyl) methyl|-n-(4-piperidinyl)-3h-imidazo£4,5-b| pyridine- -2-amine, method of its preparation and pharmaceutical agent on its base Download PDF

Info

Publication number
SK278127B6
SK278127B6 SK1987-91A SK198791A SK278127B6 SK 278127 B6 SK278127 B6 SK 278127B6 SK 198791 A SK198791 A SK 198791A SK 278127 B6 SK278127 B6 SK 278127B6
Authority
SK
Slovakia
Prior art keywords
methyl
imidazo
piperidinyl
furanyl
amine
Prior art date
Application number
SK1987-91A
Other languages
English (en)
Slovak (sk)
Inventor
Alfons Gaston Maria De Knaep
Tonny Franciscus Johanna Nelen
Frans Eduard Janssens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SK278127B6 publication Critical patent/SK278127B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Furan Compounds (AREA)
SK1987-91A 1990-07-06 1991-06-28 2-hydroxy-1,2,3-propanetricarboxylate (1:1) 3-£(5-methyl-2- -furanyl) methyl|-n-(4-piperidinyl)-3h-imidazo£4,5-b| pyridine- -2-amine, method of its preparation and pharmaceutical agent on its base SK278127B6 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54935090A 1990-07-06 1990-07-06

Publications (1)

Publication Number Publication Date
SK278127B6 true SK278127B6 (en) 1996-02-07

Family

ID=24192647

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1987-91A SK278127B6 (en) 1990-07-06 1991-06-28 2-hydroxy-1,2,3-propanetricarboxylate (1:1) 3-£(5-methyl-2- -furanyl) methyl|-n-(4-piperidinyl)-3h-imidazo£4,5-b| pyridine- -2-amine, method of its preparation and pharmaceutical agent on its base

Country Status (25)

Country Link
EP (1) EP0464927B1 (hu)
JP (1) JPH04230382A (hu)
KR (1) KR0165894B1 (hu)
CN (1) CN1026790C (hu)
AT (1) ATE142207T1 (hu)
AU (1) AU632949B2 (hu)
BG (1) BG60067B2 (hu)
CA (1) CA2043564A1 (hu)
CZ (1) CZ279435B6 (hu)
DE (1) DE69121807T2 (hu)
ES (1) ES2091285T3 (hu)
FI (1) FI94132C (hu)
GR (1) GR3020951T3 (hu)
HU (1) HUT58333A (hu)
IE (1) IE75695B1 (hu)
IL (1) IL98725A (hu)
MX (1) MX9100102A (hu)
NO (1) NO177854C (hu)
NZ (1) NZ238369A (hu)
PL (1) PL168719B1 (hu)
PT (1) PT98215B (hu)
RU (1) RU2047615C1 (hu)
SG (1) SG48825A1 (hu)
SK (1) SK278127B6 (hu)
ZA (1) ZA915241B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6211199B1 (en) 1995-11-17 2001-04-03 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
US6423704B2 (en) 1995-12-20 2002-07-23 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
US6194406B1 (en) 1995-12-20 2001-02-27 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
US5922737A (en) * 1996-02-21 1999-07-13 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
US5998439A (en) * 1996-02-21 1999-12-07 Hoescht Marion Roussel, Inc. Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
US5932571A (en) * 1996-02-21 1999-08-03 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases
KR100289063B1 (ko) * 1997-12-17 2001-05-02 정선종 누름스윗치에의한휴대전화기용자동안테나

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0144101B1 (en) * 1983-11-30 1991-02-06 Janssen Pharmaceutica N.V. Bicyclic heterocyclyl containing n-(bicyclic heterocyclyl)-4-piperidinamines
EP0232937B1 (en) * 1986-02-03 1992-08-19 Janssen Pharmaceutica N.V. Anti-histaminic compositions containing n-heterocyclyl-4-piperidinamines
GB8900380D0 (en) * 1989-01-09 1989-03-08 Janssen Pharmaceutica Nv 2-aminopyrimidinone derivatives
PH30434A (en) * 1989-04-07 1997-05-09 Janssen Pharmaceutica Nv Hydroxyalkylfuranyl derivatives

Also Published As

Publication number Publication date
NO177854B (no) 1995-08-28
PT98215B (pt) 1999-01-29
CN1026790C (zh) 1994-11-30
KR920002597A (ko) 1992-02-28
EP0464927A2 (en) 1992-01-08
ATE142207T1 (de) 1996-09-15
AU632949B2 (en) 1993-01-14
IE912362A1 (en) 1992-01-15
GR3020951T3 (en) 1996-12-31
FI913281A (fi) 1992-01-07
IE75695B1 (en) 1997-09-10
NO912650D0 (no) 1991-07-05
HU912284D0 (en) 1991-12-30
DE69121807T2 (de) 1997-01-23
PL168719B1 (pl) 1996-03-29
AU8020691A (en) 1992-01-09
FI94132B (fi) 1995-04-13
PL290956A1 (en) 1992-06-26
DE69121807D1 (de) 1996-10-10
CS198791A3 (en) 1992-03-18
PT98215A (pt) 1992-06-30
ZA915241B (en) 1993-03-31
JPH04230382A (ja) 1992-08-19
MX9100102A (es) 1992-02-28
EP0464927A3 (en) 1992-04-08
NO177854C (no) 1995-12-06
CA2043564A1 (en) 1992-01-07
NZ238369A (en) 1993-07-27
IL98725A0 (en) 1992-07-15
SG48825A1 (en) 1998-05-18
RU2047615C1 (ru) 1995-11-10
ES2091285T3 (es) 1996-11-01
EP0464927B1 (en) 1996-09-04
FI913281A0 (fi) 1991-07-05
HUT58333A (en) 1992-02-28
FI94132C (fi) 1995-07-25
BG60067B2 (en) 1993-09-30
CN1058020A (zh) 1992-01-22
CZ279435B6 (cs) 1995-04-12
NO912650L (no) 1992-01-07
IL98725A (en) 1995-07-31
KR0165894B1 (ko) 1999-01-15

Similar Documents

Publication Publication Date Title
EP0258755B1 (en) Alpha-alkyl-4-amino-3-quinoline-methanols and 1-(4-aralkylamino-3-quinolinyl) alkanones, a process for their preparation and their use as medicaments
RU2323214C2 (ru) Способы получения производных 1-[2-(бензимидазол-1-ил)хинолин-8-ил]пиперидин-4-иламина
US4977159A (en) 2-[(4-piperidyl)methyl]-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole derivatives, and their application in treating depressive state, anxiety state or hypertension
JP5518928B2 (ja) 光学活性ピペリジン誘導体の酸付加塩及びその製法
ES2217580T3 (es) Composiciones orales de levosimendan.
EP0579681B1 (en) Crystalline tiagabine hydrochloride monohydrate, its preparation and use
RU2125571C1 (ru) СОЛЬ 7-([1α,5α,6α]-6-АМИНО-3-АЗАБИЦИКЛО [3.1.0] ГЕКС-3-ИЛ)-6-ФТОР-1-(2,4-ДИФТОРФЕНИЛ)-1,4- ДИГИДРО-4-ОКСО-1,8-НАФТИРИДИН-3-КАРБОНОВОЙ И МЕТАНСУЛЬФОНОВОЙ КИСЛОТ И СПОСОБ ЕЕ ПОЛУЧЕНИЯ
AT390061B (de) Ergolinanaloga mit tricyclischer bcd-teilstruktur
US5403931A (en) (-)-(S)-2,8-dimethyl-3-methylene-1-oxa-8-azaspiro[4.5]decane L-tartrate
SK278127B6 (en) 2-hydroxy-1,2,3-propanetricarboxylate (1:1) 3-£(5-methyl-2- -furanyl) methyl|-n-(4-piperidinyl)-3h-imidazo£4,5-b| pyridine- -2-amine, method of its preparation and pharmaceutical agent on its base
CZ294964B6 (cs) Způsob přípravy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)fenyl]hydrazon]propandinitrilu s optickou čistotou nad 90 %
EP0328700A1 (en) 4,7-Dihydropyrazolo(1,5-a)pyrimidine compound and pharmaceutical use thereof
KR20090061972A (ko) 베포타스틴 ｐ-톨루엔술폰산염의 결정형, 이의 제조방법 및이를 포함하는 약학 조성물
SK12004A3 (en) Process for preparing paroxetine HCl that limits formation of pink coloured compounds
EP0170549B1 (fr) Dérivés de tétrahydro-4,5,6,7 furo ou 1H-pyrrolo[2,3-c]pyridine, leur préparation et leur application en therapeutique
KR100522574B1 (ko) 염산도네페질의다형결정및그제법
CZ216892A3 (en) 3,4-dehydropiperidine derivatives, process of their preparation and pharmaceutical compositions in which said derivatives are comprised
WO1999009028A1 (es) Formas polimorficas cristalinas de la 3-{2-[4-(6-fluorobenzo[d] isoxazol-3-il) -3,6-dihidro-2h-piridin-1-il] -etil}-2-metil-6,7, 8,9-tetrahidropirido [1,2-a]pirimidin-4-ona y procedimientos para su obtencion